11/09/2012

Researchers Confident About New Hay Fever Vaccine

Researchers at Imperial College London and King’s College London have announced a potential breakthrough in a new hay fever vaccine.

In tests, they have injected into a layer of skin on patients they think is a "hotline" to the immune system.

The researchers say their "targeted" approach could lead to a cheaper and more effective vaccine.

Allergy UK said it was a very exciting development.

Currently treatment for hay fever is largely through drugs such as antihistamines or steroids.

In very severe cases, tablets or injections of pollen under the skin can be given, which are then gradually increased over three years to boost tolerance to pollen. However, the treatment is expensive.

The research team are trying much shallower injections into a part of the skin packed with white blood cells, part of the immune system.

They argue their targeted approach means they can use tiny amounts of pollen - their dose is 2,000 times smaller than current injections - and also need fewer injections.

Speaking to the BBC, Dr Stephen Till said: "If this approach proves to be effective it would define a new scientific and clinical principle that could also be applied to other allergic diseases such as asthma and food allergies.

"This could be a pivotal study in immunological research."

(H)


Related UK National News Stories
Click here for the latest headlines.

08 April 2011
Under 18s Protected From Sunbed Dangers
Businesses will face fines of up to £20,000 if they allow under 18s to use sunbeds from today. The Sunbeds Regulation Act 2010 aims to protect under 18s in search of a year-round tan from putting their health at risk. Over-exposure to the UV rays has become the main cause of skin cancer.
05 August 2011
Building Trade 'Must Act On Skin Cancer'
Construction union UCATT are calling on the construction industry to take decisive action to ensure that the risk of construction workers developing skin cancer is dramatically reduced.
30 October 2006
'Sticking plaster' hope for skin cancer
A new light-emitting 'sticking plaster' to be used in the treatment of skin cancer, has been developed by Scottish scientists. Researchers at the University of St Andrews and Ninewells Hospital in Dundee, developed the new device, which builds on established photodynamic therapy treatment methods.
23 May 2005
Britons ‘confused’ over sun warnings
Britons are missing out on vital weather warnings that could reduce their risk of developing skin cancer, new research has revealed.
10 December 2009
Royal Mail Profits Up
Operating profits at Royal Mail grew by 4% in the six months proceeding September, it was confirmed today. Profits during this period were valued at £184m and the business injected around £300m into pension funds over this time, which is still expected to hit a deficit of over £10bn when revalued.